Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
Schizophr Res January 9, 2021 DOI: 10.1016/j.schres.2020.12.008 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA rater-blinded randomized controlled trial assessed the feasibility, acceptability, and preliminary outcomes of mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders. The therapy was found to be feasible and acceptable, with preliminary outcomes suggesting potential benefits. The study provides initial evidence supporting the use of mindfulness-based interventions in this population, though further research with larger samples is needed to confirm efficacy.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | In-patients with schizophrenia spectrum disorders |
| Intervention | Mindfulness-based group therapy |
| Key finding | Mindfulness-based group therapy was feasible and acceptable for in-patients with schizophrenia spectrum disorders, with preliminary outcomes suggesting potential benefits. |
Abstract
Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.